# IBANDRONATE SODIUM
> **ANDA079194** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2009-04-03
## Drug
- **FDA Application Number:** ANDA079194
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBANDRONATE SODIUM
- **Generic name:** Ibandronate Sodium
- **Active ingredients:** IBANDRONATE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** TEVA PARENTERAL
- **First approval:** 2009-04-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079194)
---
*AI Analytics · CC0 1.0*